Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 60

1.

Pharmacological aspects of acid secretion.

Hirschowitz BI, Keeling D, Lewin M, Okabe S, Parsons M, Sewing K, Wallmark B, Sachs G.

Dig Dis Sci. 1995 Feb;40(2 Suppl):3S-23S. Review.

PMID:
7859583
2.

The pharmacology of the gastric acid pump: the H+,K+ ATPase.

Sachs G, Shin JM, Briving C, Wallmark B, Hersey S.

Annu Rev Pharmacol Toxicol. 1995;35:277-305. Review.

PMID:
7598495
3.

Characterization of proton transport in bone-derived membrane vesicles.

Mattsson JP, Lorentzon P, Wallmark B, Keeling DJ.

Biochim Biophys Acta. 1993 Feb 23;1146(1):106-12.

PMID:
8443216
4.

Characterization of proton transport in bone-derived membrane vesicles.

Mattsson JP, Wallmark B, Lorentzon P, Keeling DJ.

Acta Physiol Scand Suppl. 1992;607:253-7.

PMID:
1449069
5.

Omeprazole and bafilomycin, two proton pump inhibitors: differentiation of their effects on gastric, kidney and bone H(+)-translocating ATPases.

Mattsson JP, Väänänen K, Wallmark B, Lorentzon P.

Biochim Biophys Acta. 1991 Jun 18;1065(2):261-8.

PMID:
1647821
7.

Changes induced in growing rat bone by immobilization and remobilization.

Tuukkanen J, Wallmark B, Jalovaara P, Takala T, Sjögren S, Väänänen K.

Bone. 1991;12(2):113-8.

PMID:
2064838
8.

Partial pronase digestion of rat gastric mucosa isolates cells undergoing replicative DNA synthesis.

Larsson H, Fryklund J, Helander HF, Wallmark B.

Mutagenesis. 1991 Jan;6(1):3-9.

PMID:
2038270
9.

Evidence for the presence of a proton pump of the vacuolar H(+)-ATPase type in the ruffled borders of osteoclasts.

Väänänen HK, Karhukorpi EK, Sundquist K, Wallmark B, Roininen I, Hentunen T, Tuukkanen J, Lakkakorpi P.

J Cell Biol. 1990 Sep;111(3):1305-11.

10.

Coupling of H(+)-K(+)-ATPase activity and glucose oxidation in gastric glands.

Fryklund J, Gedda K, Scott D, Sachs G, Wallmark B.

Am J Physiol. 1990 May;258(5 Pt 1):G719-27.

PMID:
2159239
11.

Inhibition of osteoclast proton transport by bafilomycin A1 abolishes bone resorption.

Sundquist K, Lakkakorpi P, Wallmark B, Väänänen K.

Biochem Biophys Res Commun. 1990 Apr 16;168(1):309-13.

PMID:
2139331
12.

Omeprazole: the first proton pump inhibitor.

Lindberg P, Brändström A, Wallmark B, Mattsson H, Rikner L, Hoffmann KJ.

Med Res Rev. 1990 Jan-Mar;10(1):1-54. Review. No abstract available.

PMID:
2404184
13.

Effect of 20 weeks' ranitidine treatment on plasma gastrin levels and gastric enterochromaffin-like cell density in the rat.

Wallmark B, Skånberg I, Mattsson H, Andersson K, Sundler F, Håkanson R, Carlsson E.

Digestion. 1990;45(4):181-8.

PMID:
2401392
14.

The gastric H+,K(+)-ATPase.

Wallmark B, Lorentzon P, Sachs G.

J Intern Med Suppl. 1990;732:3-8. Review.

PMID:
2166525
15.

Tritiated thymidine incorporation into DNA in rat gastric mucosal cells.

Wallmark B, Larsson H, Andersson K, Fryklund J, Helander HF.

Digestion. 1990;47 Suppl 1:39-44.

PMID:
2093014
16.

Pharmacological agents of gastric acid secretion: receptor antagonists and pump inhibitors.

Wallmark B, Fryklund J.

Methods Enzymol. 1990;191:721-38. No abstract available.

PMID:
1963658
17.

Omeprazole: mode of action and effect on acid secretion in animals.

Wallmark B.

Methods Find Exp Clin Pharmacol. 1989;11 Suppl 1:101-6. Review.

PMID:
2657278
18.

Biological basis of omeprazole therapy.

Sachs G, Wallmark B.

J Gastroenterol Hepatol. 1989;4 Suppl 2:7-18. Review.

PMID:
2562365
19.

The gastric H+,K+-ATPase: the site of action of omeprazole.

Sachs G, Wallmark B.

Scand J Gastroenterol Suppl. 1989;166:3-11. Review.

PMID:
2557669
20.

Omeprazole: mode of action and effect on acid secretion in animals.

Wallmark B.

Scand J Gastroenterol Suppl. 1989;166:12-8. Review.

PMID:
2557668
21.

Ion permeability and pump regulation.

Lorentzon P, Hersey SJ, Wallmark B, Sachs G.

Ann N Y Acad Sci. 1989;574:134-44. No abstract available.

PMID:
2534497
22.

Inhibition of gastric H+/K+-ATPase by substituted imidazo[1,2-a]pyridines.

Briving C, Andersson BM, Nordberg P, Wallmark B.

Biochim Biophys Acta. 1988 Dec 22;946(2):185-92.

PMID:
2850003
23.

Time-course of development and reversal of gastric endocrine cell hyperplasia after inhibition of acid secretion. Studies with omeprazole and ranitidine in intact and antrectomized rats.

Larsson H, Carlsson E, Håkanson R, Mattsson H, Nilsson G, Seensalu R, Wallmark B, Sundler F.

Gastroenterology. 1988 Dec;95(6):1477-86.

PMID:
3181674
24.
25.
26.

The catalytic mechanism of gastric H+/K+-ATPase: simulations of pre-steady-state and steady-state kinetic results.

Brzezinski P, Malmström BG, Lorentzon P, Wallmark B.

Biochim Biophys Acta. 1988 Jul 21;942(2):215-9.

PMID:
2840118
27.

Pharmacology of the proton pump.

Wallmark B.

S Afr Med J. 1988 Jul 2;74 Suppl:4-7. No abstract available.

PMID:
3388167
28.

Specific labelling of gastric H+,K+-ATPase by omeprazole.

Fryklund J, Gedda K, Wallmark B.

Biochem Pharmacol. 1988 Jul 1;37(13):2543-9.

PMID:
2839196
29.

Function and structure of parietal cells after H+-K+-ATPase blockade.

Fryklund J, Helander HF, Elander B, Wallmark B.

Am J Physiol. 1988 Mar;254(3 Pt 1):G399-407.

PMID:
2831735
30.

Gastric H,K-ATPase as therapeutic target.

Sachs G, Carlsson E, Lindberg P, Wallmark B.

Annu Rev Pharmacol Toxicol. 1988;28:269-84. Review. No abstract available.

PMID:
2898235
31.

The gastric H+,K+-ATPase.

Lorentzon P, Scott D, Hersey S, Wallmark B, Rabon E, Sachs G.

Prog Clin Biol Res. 1988;273:247-54. Review. No abstract available.

PMID:
2843917
32.

Rat parietal cell function after prolonged inhibition of gastric acid secretion.

Larsson H, Carlsson E, Ryberg B, Fryklund J, Wallmark B.

Am J Physiol. 1988 Jan;254(1 Pt 1):G33-9.

PMID:
2827515
33.

Inhibition of gastric H+,K+-ATPase and acid secretion by SCH 28080, a substituted pyridyl(1,2a)imidazole.

Wallmark B, Briving C, Fryklund J, Munson K, Jackson R, Mendlein J, Rabon E, Sachs G.

J Biol Chem. 1987 Feb 15;262(5):2077-84.

34.

Inhibition of (H+ + K+)-ATPase by omeprazole in isolated gastric vesicles requires proton transport.

Lorentzon P, Jackson R, Wallmark B, Sachs G.

Biochim Biophys Acta. 1987 Feb 12;897(1):41-51.

PMID:
3026477
35.

Omeprazole, a new antiulcer drug with a unique mechanism of action.

Lindberg P, Brändström A, Wallmark B.

Acta Pharm Suec. 1987;24(6):329-32. Review. No abstract available.

PMID:
3330896
36.

The mechanism of action of the gastric acid secretion inhibitor omeprazole.

Lindberg P, Nordberg P, Alminger T, Brändström A, Wallmark B.

J Med Chem. 1986 Aug;29(8):1327-9. No abstract available.

PMID:
3016260
37.

Inhibitory action of omeprazole on acid formation in gastric glands and on H+,K+-ATPase isolated from human gastric mucosa.

Elander B, Fellenius E, Leth R, Olbe L, Wallmark B.

Scand J Gastroenterol. 1986 Apr;21(3):268-72.

PMID:
3012768
38.

Plasma gastrin and gastric enterochromaffinlike cell activation and proliferation. Studies with omeprazole and ranitidine in intact and antrectomized rats.

Larsson H, Carlsson E, Mattsson H, Lundell L, Sundler F, Sundell G, Wallmark B, Watanabe T, Håkanson R.

Gastroenterology. 1986 Feb;90(2):391-9.

PMID:
3510144
39.

Mechanism of action of omeprazole.

Wallmark B.

Scand J Gastroenterol Suppl. 1986;118:11-7.

PMID:
3014640
40.
41.

The relationship between gastric acid secretion and gastric H+,K+-ATPase activity.

Wallmark B, Larsson H, Humble L.

J Biol Chem. 1985 Nov 5;260(25):13681-4.

42.

The mechanism for inhibition of gastric (H+ + K+)-ATPase by omeprazole.

Lorentzon P, Eklundh B, Brändström A, Wallmark B.

Biochim Biophys Acta. 1985 Jul 11;817(1):25-32.

PMID:
2988621
43.

The mechanism of action of omeprazole--a survey of its inhibitory actions in vitro.

Wallmark B, Lorentzon P, Larsson H.

Scand J Gastroenterol Suppl. 1985;108:37-51.

PMID:
2988109
44.

Evidence for acid-induced transformation of omeprazole into an active inhibitor of (H+ + K+)-ATPase within the parietal cell.

Wallmark B, Brändström A, Larsson H.

Biochim Biophys Acta. 1984 Dec 19;778(3):549-58.

PMID:
6095911
45.

[Acid secretion inhibition with new mechanisms of action: substituted benzimidazole].

Olbe L, Lind T, Carlsson E, Cederberg C, Helander H, Wallmark B.

Schweiz Med Wochenschr. 1984 May 19;114(20):683-5. German.

PMID:
6740286
46.

Effect of omeprazole on gastric secretion in H+,K+-ATPase and in pepsinogen-rich cell fractions from rabbit gastric mucosa.

Fryklund J, Wallmark B, Larsson H, Helander HF.

Biochem Pharmacol. 1984 Jan 15;33(2):273-80.

PMID:
6322797
47.

Differentiation among inhibitory actions of omeprazole, cimetidine, and SCN- on gastric acid secretion.

Wallmark B, Jaresten BM, Larsson H, Ryberg B, Brändström A, Fellenius E.

Am J Physiol. 1983 Jul;245(1):G64-71.

PMID:
6307064
48.

A micro-method for the study of acid secretory function in isolated human oxyntic glands from gastroscopic biopsies.

Fellenius E, Elander B, Wallmark B, Haglund U, Helander HF, Olbe L.

Clin Sci (Lond). 1983 Apr;64(4):423-31. No abstract available.

PMID:
6297844
49.

Inhibition of gastric (H+ + K+)-ATPase by the substituted benzimidazole, picoprazole.

Wallmark B, Sachs G, Mardh S, Fellenius E.

Biochim Biophys Acta. 1983 Feb 9;728(1):31-8.

PMID:
6299338
50.

Inhibition of acid secretion in isolated gastric glands by substituted benzimidazoles.

Fellenius E, Elander B, Wallmark B, Helander HF, Berglindh T.

Am J Physiol. 1982 Dec;243(6):G505-10.

PMID:
6293317

Supplemental Content

Loading ...
Support Center